Press release
U.S. Vancomycin Market Was Valued At US$ 84.5 Mn in 2020 and Is Anticipated To Rise at the Highest CAGR over the Forecast Period
The global vancomycin market is projected to increase from a valuation of US$ 313.7 Mn in 2020 to US$ 465.1 Mn by the end of 2027. Demand for vancomycin to expand at a CAGR of 5.8% during the forecast period.Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.
To remain 'ahead' of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=7293
The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Vancomycin Therapeutics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Vancomycin Therapeutics
The report offers actionable and valuable market insights of Vancomycin Therapeutics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Vancomycin Therapeutics Market across various industries and regions
Key Companies Profiled
• Alvogen
• MGB Biopharma Limited
• Oragenics
• Aphios Corporation
• Microbiotix
Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=7293
Competitive Landscape
Vancomycin is a competitive and moderately fragmented market. There are many players in the sector under scrutiny, including both, small and large pharmaceutical companies. Furthermore, a wave of early-stage biotech companies has entered the market in response to developing antibiotic resistance.
For instance :
In February 2022, Magnolia Medical Technologies, Inc., the producer of Steripath®, which is the only FDA 510(k)-complaint device platform for the reduction of blood culture contamination for sepsis testing1, revealed US$ 46 million of growth equity financing led by RTW Investments, LP ("RTW"), and Sectoral Asset Management.
Key Segments Covered in Vancomycin Industry Research
Vancomycin Market by Type :
• Daptomycin
• Linezolid
• Quinupristin
• Ampicillin
• Chloramphenicol
• Others
Vancomycin Market by Application
• Sepsis
• Lung Infection
• Skin Soft Tissue Infection
• Colitis & Intestinal Inflammation
• Other Infections
Vancomycin Market by Region :
• North America Vancomycin Market
• Europe Vancomycin Market
• Asia Pacific Vancomycin Market
• Latin America Vancomycin Market
• MEA Vancomycin Market
Read More Trending Reports of Fact.MR-
https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/
Explore Fact.MR's Comprehensive Coverage on Healthcare Domain:
Fluoro Enzymatic Assays Market - https://www.factmr.com/report/fluoro-enzymatic-assays-market
Shower Chairs Market - https://www.factmr.com/report/shower-chairs-market
Infrared Thermometer Market - https://www.factmr.com/report/infrared-thermometer-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Vancomycin Market Was Valued At US$ 84.5 Mn in 2020 and Is Anticipated To Rise at the Highest CAGR over the Forecast Period here
News-ID: 2658457 • Views: …
More Releases from Fact.MR
Global SAP Cloud Platform Services Market is likely to reach a valuation of USD …
Fact.MR recently conducted a study on the global SAP cloud platform services market is anticipated to surge from USD 443 million in 2022 to a staggering USD 7,000 million by 2032. This remarkable growth trajectory is projected to unfold at an exhilarating compound annual growth rate (CAGR) of 31% over the period spanning from 2022 to 2032.
This analysis delves into pivotal trends shaping the market's growth trajectory. The report elucidates…
Mobile Value Added Service Market is projected to rise at a CAGR of 14.9% throug …
As per a recent study conducted by Fact.MR, a prominent provider of market research and competitive intelligence, the global Mobile Value Added Service Market is valued at approximately US$ 880.4 million in 2024. Forecasts indicate a robust compound annual growth rate (CAGR) of 14.9% through 2034, with the market anticipated to exceed a valuation of US$ 3,522.6 million by the end of that period.
Intense competition among smartphone manufacturers has led…
GMP Cell Banking Service Market value is projected to reach US$ 3,123.5 million …
According to Fact.MR, a leading provider of market research and competitive intelligence, the global GMP Cell Banking Service Market is anticipated to reach approximately US$ 882.1 million by 2024. Over the period from 2024 to 2034, the market for GMP cell banking services is expected to witness a robust growth rate of 13.7%. The report further forecasts that the market will attain an overall valuation of US$ 3,123.5 million by…
Global High Fiber Feed Market value is projected to reach US$ 524.1 million by 2 …
According to Fact.MR, a leading provider of market research and competitive intelligence, the High Fiber Feed Market achieved a value of approximately US$ 276.3 million in 2019. Projections suggest a notable growth trajectory, with demand expected to increase at a Compound Annual Growth Rate (CAGR) of 4.4% from 2024 to 2034. By 2034, the market is anticipated to reach US$ 524.1 million.
The escalating global population and rising incomes have fueled…
More Releases for Vancomycin
Vancomycin Market Trends, Business Overview, Industry Growth and Forecast to 202 …
The global vancomycin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Vancomycin is a class of medication called glycopeptides antibiotics. It works by preventing bacteria that cause infection. The rise in the prevalence of lung infections such as pneumonia, bronchitis, and others is anticipated to drive the growth of the global vancomycin market. For instance, according to the data published by World Health Organization…
Vancomycin Market Latest Trend and Development 2020-2026
The Vancomycin Market research report consists of market analysis, growth, trends, forecast, and comprehensive strategies in the future. It also assists with strategic and planning decisions that incorporate the necessary information to perform PEST, SWOT, and STEER analysis. Moreover, the Vancomycin Market report analyzes the critical performance and operational metrics so that you can plan robust business strategies.
Download a FREE Sample Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4800576
The report consists a detailed analysis of…
Vancomycin-Resistant Staphylococcus aureus Infections Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2017, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline landscape.
Vancomycin resistant staphylococcus infection is a condition caused by bacteria (germs) . This infection occurs when bacteria, called Staphylococcus aureus or Staph, becomes resistant (not killed) to the antibiotic medicine vancomycin. Risk factors include taking strong antibiotics the wrong…
Vancomycin Resistant Staphylococcus Aureus Infection Market Key Trends and Oppor …
Staphylococcus aureus is an anaerobic gram positive bacteria, commonly found in the respiratory tract of human and on the skin. This strain of bacteria is always not pathogenic but remains a major cause for respiratory diseases, skin infections and food poisoning. S.aureus strains often promote infections by producing harmful protein toxins. It is anticipated that approximately 20% of the population carries S.aureus in the anterior part of nasal passages and…
Vancomycin Market Global Industry Analysis, Size, Share, Growth, Trends and Fore …
Global and Chinese Vancomycin Industry Research Report of 150 pages with 91 Figures and Tables 8 company profiles to the Chemicals industry segment of its online data and intelligence library.
The Global and Chinese Vancomycin Industry, 2012-2022 Market Research Report is an exhaustive study on the present market scenario of the global Vancomycin Market with a special focus on the China market of this Industry. The report summarizes key statistics of…
Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Market : Evolving Te …
Global Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Market: Brief Description
Staphylococcus aureus is an anaerobic gram positive bacteria, commonly found in the respiratory tract of human and on the skin. This strain of bacteria is always not pathogenic but remains a major cause for respiratory diseases, skin infections and food poisoning. S.aureus strains often promote infections by producing harmful protein toxins. It is anticipated that approximately 20% of the population…
